Multi-country Survey on Violence Against Women Among Women

April 2, 2024 updated by: Unnop Jaisamrarn, Chulalongkorn University

Multi-country Survey on Violence Against Women Among Reproductive-aged Women

The goal of this observational study is to explore and learn about violence against women (VAW) among reproductive-aged women in Asia and Oceania countries. The main questions it aims to answer are:

  • pattern and prevalence of VAW among reproductive-aged women
  • knowledge, attitude, and practice (KAP) towards VAW among reproductive-aged women
  • the need of support services for VAW among reproductive-aged women

Participants will be ever-partnered women aged 15-49 years. The definition of "ever-partnered women" included women who have current and former husbands; current and former cohabiting; or non-cohabiting male intimate partners.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Violence against women (VAW) is a global issue that threatens women's physical and emotional wellbeing, and impacts women worldwide, regardless of age, race, ethnicity, or nationality. This survey aims to investigate 1) the pattern and prevalence of VAW among reproductive-aged women; 2) the knowledge, attitude, and practice (KAP) towards VAW among reproductive-aged women; and 3) the need of support services for VAW among reproductive-aged women.

This multinational, hospital-based, cross-sectional study will be carried out in Asia and Oceania countries. We will select the Obstetrics and Gynecology Outpatient Department or Women Health Unit in each nation. Minimum of 400 female citizen in each country will be recruited if they are aged 15-49 years, ever-partnered women, and agree to finish the questionnaire.

The questionnaire, developed in English with inputs from literature and experts, comprises four sections: 1) basic participant characteristics, 2) patterns and prevalence of violence, 3) knowledge, attitudes, and practices towards violence, and 4) the need for support services. A pilot study will validate and translate the questionnaire into the target languages, ensuring content relevance and sensitivity to the target culture through forward and backward translation processes. The reliability of the questionnaire will be assessed using Cronbach's alpha.

Data collection involves preparatory steps such as developing a training manual for interviewers, addressing potential issues, and advertising the survey. Central investigators will monitor the data collection process, with data collected through self-administered questionnaires. The use of REDCap software aims to manage surveys efficiently and prevent multiple participations. A paper-based questionnaire could be used in some areas when necessary.

Study Type

Observational

Enrollment (Estimated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Women in Asia and Oceania countries, who register at the Obstetrics and Gynecology Outpatient Department or Women Health Unit. Participant's biological sex should be female.

Description

Inclusion Criteria:

  • ever-partnered women
  • aged 15-49 years

The definition of "ever-partnered women" included women who have current and former husbands; current and former cohabiting; or non-cohabiting male intimate partners.

Exclusion Criteria:

  • declined to participate
  • dropped out midway

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Reproductive aged women
Reproductive aged women in Asia and Oceania countries

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prevalence of violence against women
Time Frame: through study completion, an average of 1 year
using questionnaire to explore the prevalence of various forms of violence against women
through study completion, an average of 1 year
KAP towards violence against women
Time Frame: through study completion, an average of 1 year
using questionnaire to explore knowledge, attitude, and practice towards violence against women
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
need of support services for violence against women
Time Frame: through study completion, an average of 1 year
using questionnaire to identify the need of support services for violence against women among reproductive-aged women
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chulalongkorn University

Collaborators

Asia and Oceania Federation of Obstetrics and Gynaecology

Investigators

  • Principal Investigator: Unnop Jaisamrarn, MD,MHS, Chulalongkorn University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

March 19, 2024

First Submitted That Met QC Criteria

April 2, 2024

First Posted (Actual)

April 9, 2024

Study Record Updates

Last Update Posted (Actual)

April 9, 2024

Last Update Submitted That Met QC Criteria

April 2, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 0562/66

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Since this will be a multinational survey, we will decide after discussing about this issue with investigators of each country.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Violence Against Women

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe